BAX

SEC source: 0001495559-25-000007 · wk-form4_1757023215.xml · nonDerivative · entry 1

Borzi James W · CIK 0001495559 · EVP,Chief Supply Chain Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,948

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on September 2, 2025 from the settlement of vested restricted stock units granted on September 1, 2023.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001728374-25-000006 · wk-form4_1755807420.xml · nonDerivative · entry 1

Shafer David Brent · CIK 0001728374 · Director · Chair of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,446

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on August 19, 2025 from the settlement of vested restricted stock units granted on February 5, 2025, which units vested in accordance with the Amended and Restated Letter Agreement, dated August 2, 2025, by and between Brent Shafer and Baxter International Inc.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0000010456-25-000003 · wk-form4_1749067575.xml · nonDerivative · entry 1

Rosenbloom David S. · CIK 0001924321 · EVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,327

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on June 2, 2025 from the settlement of vested restricted stock units granted on June 1, 2022.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001062993-25-008905 · form4.xml · nonDerivative · entry 1

Wilkes David S. · CIK 0001842866 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,906

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001062993-25-008903 · form4.xml · nonDerivative · entry 1

Smith Cathy R · CIK 0001322028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,345

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001062993-25-008904 · form4.xml · nonDerivative · entry 1

Wendell Amy McBride · CIK 0001400568 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,222

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001062993-25-008902 · form4.xml · nonDerivative · entry 1

SCHLICHTING NANCY M · CIK 0001376358 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,850

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001062993-25-008901 · form4.xml · nonDerivative · entry 1

RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,499

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001062993-25-008900 · form4.xml · nonDerivative · entry 1

Oesterle Stephen N. · CIK 0001174532 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,847

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001062993-25-008899 · form4.xml · nonDerivative · entry 1

MORRISON PATRICIA · CIK 0001204081 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,137

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001062993-25-008897 · form4.xml · nonDerivative · entry 1

Ampofo William A. II · CIK 0001983479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,299

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001628280-25-023822 · wk-form4_1746735418.xml · nonDerivative · entry 1

Craig Jeffrey A · CIK 0001360603 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,672

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001062993-25-005029 · form4.xml · nonDerivative · entry 1

Zielinski Anita A · CIK 0001703384 · SVP, CAO and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,123

F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

SEC source: 0001062993-25-005028 · form4.xml · derivative · entry 3

Sonig Alok · CIK 0001967368 · EVP,Group President,Pharma

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,905

Underlying: Common Stock, $1 par value · 99,905 shares

Expires 2035-03-06

F3 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date.

SEC source: 0001062993-25-005028 · form4.xml · nonDerivative · entry 2

Sonig Alok · CIK 0001967368 · EVP,Group President,Pharma

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,298

F2 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

SEC source: 0001062993-25-005028 · form4.xml · nonDerivative · entry 1

Sonig Alok · CIK 0001967368 · EVP,Group President,Pharma

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,332

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2025 from the settlement of vested restricted stock units granted on March 6, 2024.

SEC source: 0001062993-25-005027 · form4.xml · derivative · entry 3

Rosenbloom David S. · CIK 0001924321 · EVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,873

Underlying: Common Stock, $1 par value · 58,873 shares

Expires 2035-03-06

F3 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date.

SEC source: 0001062993-25-005027 · form4.xml · nonDerivative · entry 2

Rosenbloom David S. · CIK 0001924321 · EVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,438

F2 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

SEC source: 0001062993-25-005027 · form4.xml · nonDerivative · entry 1

Rosenbloom David S. · CIK 0001924321 · EVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,780

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2025 from the settlement of vested restricted stock units granted on March 6, 2024.

SEC source: 0001062993-25-005026 · form4.xml · derivative · entry 3

Rasul Reazur · CIK 0001967379 · EVP,Group Pres,Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,417

Underlying: Common Stock, $1 par value · 87,417 shares

Expires 2035-03-06

F3 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date.

SEC source: 0001062993-25-005026 · form4.xml · nonDerivative · entry 2

Rasul Reazur · CIK 0001967379 · EVP,Group Pres,Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,614

F2 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

SEC source: 0001062993-25-005026 · form4.xml · nonDerivative · entry 1

Rasul Reazur · CIK 0001967379 · EVP,Group Pres,Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,394

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2025 from the settlement of vested restricted stock units granted on March 6, 2024.

SEC source: 0001062993-25-005025 · form4.xml · derivative · entry 3

Mason Jeanne K · CIK 0001362109 · EVP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,331

Underlying: Common Stock, $1 par value · 52,331 shares

Expires 2035-03-06

F3 · derivative.exercise_date: The options which become exercisable in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date.

SEC source: 0001062993-25-005025 · form4.xml · nonDerivative · entry 2

Mason Jeanne K · CIK 0001362109 · EVP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 199,659

F2 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

SEC source: 0001062993-25-005025 · form4.xml · nonDerivative · entry 1

Mason Jeanne K · CIK 0001362109 · EVP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 183,963

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2025 from the settlement of vested restricted stock units granted on March 6, 2024.

SEC source: 0001062993-25-005024 · form4.xml · derivative · entry 3

Knight Heather · CIK 0001967528 · EVP, Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,934

Underlying: Common Stock, $1 par value · 118,934 shares

Expires 2035-03-06

F3 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date.

SEC source: 0001062993-25-005024 · form4.xml · nonDerivative · entry 2

Knight Heather · CIK 0001967528 · EVP, Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 177,362

F2 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

SEC source: 0001062993-25-005024 · form4.xml · nonDerivative · entry 1

Knight Heather · CIK 0001967528 · EVP, Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,688

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2025 from the settlement of vested restricted stock units granted on March 6, 2024.

SEC source: 0001062993-25-005022 · form4.xml · derivative · entry 3

Borzi James W · CIK 0001495559 · EVP,Chief Supply Chain Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,302

Underlying: Common Stock, $1 par value · 33,302 shares

Expires 2035-03-06

F3 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date.

SEC source: 0001062993-25-005022 · form4.xml · nonDerivative · entry 2

Borzi James W · CIK 0001495559 · EVP,Chief Supply Chain Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,134

F2 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date.

SEC source: 0001062993-25-005022 · form4.xml · nonDerivative · entry 1

Borzi James W · CIK 0001495559 · EVP,Chief Supply Chain Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,145

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2025 from the settlement of vested restricted stock units granted on March 6, 2024.

SEC source: 0001062993-25-005023 · form4.xml · derivative · entry 3

Grade Joel T. · CIK 0001602507 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,478

Underlying: Common Stock, $1 par value · 98,478 shares

Expires 2035-03-06

F4 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date.

SEC source: 0001062993-25-005023 · form4.xml · nonDerivative · entry 2

Grade Joel T. · CIK 0001602507 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,434

F2 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 6, 2026, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.

F3 · balance_after: Total includes the automatic reinvestment of dividends and shares held in the Baxter's Employee Stock Plan.

SEC source: 0001062993-25-005023 · form4.xml · nonDerivative · entry 1

Grade Joel T. · CIK 0001602507 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,896

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2025 from the settlement of vested restricted stock units granted on March 6, 2024.

SEC source: 0001062993-25-004536 · form4.xml · nonDerivative · entry 1

Sonig Alok · CIK 0001967368 · EVP,Group President,Pharma

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,171

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 3, 2025 from the settlement of vested restricted stock units granted on March 1, 2023.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001062993-25-004534 · form4.xml · nonDerivative · entry 1

Rosenbloom David S. · CIK 0001924321 · EVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,703

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 3, 2025 from the settlement of vested restricted stock units granted on March 1, 2023.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001062993-25-004533 · form4.xml · nonDerivative · entry 1

Rasul Reazur · CIK 0001967379 · EVP,Group Pres,Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,735

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 3, 2025 from the settlement of vested restricted stock units granted on March 2, 2022 and March 1, 2023.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001062993-25-004532 · form4.xml · nonDerivative · entry 1

Mason Jeanne K · CIK 0001362109 · EVP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188,339

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 3, 2025 from the settlement of vested restricted stock units granted on March 2, 2022 and March 1, 2023.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001062993-25-004531 · form4.xml · nonDerivative · entry 1

Knight Heather · CIK 0001967528 · EVP, Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,323

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 3, 2025 from the settlement of vested restricted stock units granted on March 2, 2022 and March 1, 2023.

F2 · balance_after: Total includes the automatic reinvestment of dividends and shares held in the Baxter's Employee Stock Plan.

SEC source: 0001062993-25-004530 · form4.xml · nonDerivative · entry 1

Borzi James W · CIK 0001495559 · EVP,Chief Suppy Chain Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,407

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 3, 2025 from the settlement of vested restricted stock units granted on March 2, 2022 and March 1, 2023.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001062993-25-001803 · form4.xml · nonDerivative · entry 1

Shafer David Brent · CIK 0001728374 · Director · Interim CEO and Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,841

F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest the earlier of the six month anniversary of February 3, 2025 and the first date of employment of the reporting person's successor as chief executive officer.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001062993-25-001606 · form4.xml · nonDerivative · entry 1

Toth Christopher A. · CIK 0001753950 · EVP, Group Pres, Kidney Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,186

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on January 31, 2025 from the settlement of restricted stock units granted on March 6, 2024. These shares vested on January 31, 2025 in accordance with the terms of that Equity Purchase Agreement, dated as of August 12, 2024 (as amended), by and among Baxter International Inc. and certain Carlyle affiliates (the "EPA").

F2 · balance_after: Adjusted to reflect (i) automatic reinvestment of dividends, and (ii) the number of shares forfeited by the reporting person in connection with the closing of the EPA, as further described in the Issuer's Form 8-K filed on February 3, 2025.

SEC source: 0001062993-25-000127 · form4.xml · nonDerivative · entry 1

Toth Christopher A. · CIK 0001753950 · EVP,Group Pres, Kidney Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 183,876

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on December 31, 2024 from the settlement of vested restricted stock units granted on June 1, 2023.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001062993-24-020756 · form4.xml · nonDerivative · entry 1

ALMEIDA JOSE E · CIK 0001216761 · Chairman, CEO, President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 243,589

F1 · kind: Represents the number of shares forfeited by the reporting person to cover the withholding of accelerated FICA taxes for restricted stock unit awards previously granted under Baxter International Inc.'s Long-Term Incentive Plan.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001062993-24-020053 · form4.xml · nonDerivative · entry 1

Rasul Reazur · CIK 0001967379 · EVP,Group Pres,Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,116

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on December 2, 2024 from the settlement of vested restricted stock units granted on December 1, 2021.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001062993-24-020052 · form4.xml · nonDerivative · entry 1

Knight Heather · CIK 0001967528 · EVP, Group Pres, Med Products

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,674

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on December 2, 2024 from the settlement of vested restricted stock units granted on December 1, 2021.

F2 · balance_after: Total includes the automatic reinvestment of dividends and shares held in the Baxter's Employee Stock Plan.

SEC source: 0001062993-24-020051 · form4.xml · nonDerivative · entry 1

Grade Joel T. · CIK 0001602507 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,457

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on December 2, 2024 from the settlement of vested restricted stock units granted on December 1, 2023.

F2 · balance_after: Total includes the automatic reinvestment of dividends and shares held in the Baxter's Employee Stock Plan.

SEC source: 0001062993-24-016454 · form4.xml · nonDerivative · entry 1

Craig Jeffrey A · CIK 0001360603 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,472

F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.

SEC source: 0001062993-24-016210 · form4.xml · nonDerivative · entry 1

Sonig Alok · CIK 0001967368 · EVP,Group President, Pharma

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,603

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on September 3, 2024 from the settlement of vested restricted stock units granted on September 1, 2022.

F2 · balance_after: Total includes the automatic reinvestment of dividends.

SEC source: 0001062993-24-016209 · form4.xml · nonDerivative · entry 1

Borzi James W · CIK 0001495559 · EVP,Chief Supply Chain Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,853

F1 · shares: Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on September 3, 2024 from the settlement of vested restricted stock units granted on September 1, 2023.

F2 · balance_after: Total includes the automatic reinvestment of dividends.